Table 2.

Clinical characteristics for the SYSUCC CRC cohort.

	Total (n = 53)	CXCL13−TLS− (n = 21)	CXCL13+TLS− (n = 14)	CXCL13+TLS+ (n = 18)	P
Gender					0.3672
Female	23	7	8	8
Male	30	14	6	10
Age, y					0.2251
<50	27	9	10	8
≥50	26	12	4	10
Stage					0.5929
T3	20	7	7	6
T4	33	14	7	12